Compare ALNY & FIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALNY | FIX |
|---|---|---|
| Founded | 2002 | 1917 |
| Country | United States | United States |
| Employees | 115 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.1B | 45.0B |
| IPO Year | 2004 | 1997 |
| Metric | ALNY | FIX |
|---|---|---|
| Price | $323.00 | $1,602.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 28 | 4 |
| Target Price | $471.93 | ★ $1,378.67 |
| AVG Volume (30 Days) | ★ 1.1M | 338.9K |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.18% |
| EPS Growth | ★ 206.88 | 97.81 |
| EPS | 2.33 | ★ 28.88 |
| Revenue | $1,037,418,000.00 | ★ $9,101,641,000.00 |
| Revenue This Year | $52.99 | $21.47 |
| Revenue Next Year | $31.77 | $13.42 |
| P/E Ratio | $137.81 | ★ $54.56 |
| Revenue Growth | 22.88 | ★ 29.52 |
| 52 Week Low | $225.84 | $321.95 |
| 52 Week High | $495.55 | $1,601.90 |
| Indicator | ALNY | FIX |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 65.80 |
| Support Level | $302.52 | $1,262.85 |
| Resistance Level | $330.33 | N/A |
| Average True Range (ATR) | 10.91 | 72.68 |
| MACD | 1.16 | 16.67 |
| Stochastic Oscillator | 62.72 | 95.37 |
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway in cells that enables sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
Comfort Systems USA Inc provides comprehensive mechanical contracting services, including heating, ventilation, & air conditioning, or HVAC; plumbing; piping & controls; construction; and other electrical components. Projects are mainly for commercial, industrial, & institutional buildings, & tend to be geared toward HVAC. Revenue is roughly split between installation services for newly constructed facilities & maintenance services for existing buildings. The company installs & repairs products and systems throughout the United States. It operates in two segments, Mechanical services & Electrical services, the majority is from the Mechanical services segment.